OBJECTIVE: The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) aims to establish the efficacy of 2 different ovarian cancer screening schedules. The psychosocial substudy examines the psychological factors associated with the screening program. METHODS: Women aged 50 to 75 years from 16 UK gynecologic centers randomized to annual multimodal screening or ultrasound screening (US) groups were followed up for 7 years. Psychosocial data from women who withdrew from the study after a repeat screen were examined. RESULTS: Sixteen percent (3499/21,733) of women requiring a repeat screening test in addition to annual screen withdrew from the study: 12.9% (1560/12,073) from the multimodal group and 20.1% (1939/9660) from the...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Evaluation of costs and benefits associated with cancer screening should include consideration of an...
Objective: The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) aims to esta...
Objective To examine the psychological sequelae associated with abnormal screening in the United Kin...
OBJECTIVE: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
Objective A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
OBJECTIVES: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
OBJECTIVES: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Background: Ovarian cancer is known as the “silent killer”. A prospective psychological evaluation s...
Background: Ovarian cancer is known as the “silent killer”. A prospective psychological evaluation s...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Evaluation of costs and benefits associated with cancer screening should include consideration of an...
Objective: The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) aims to esta...
Objective To examine the psychological sequelae associated with abnormal screening in the United Kin...
OBJECTIVE: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
Objective A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
OBJECTIVES: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
OBJECTIVES: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Objectives Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthl...
Background: Ovarian cancer is known as the “silent killer”. A prospective psychological evaluation s...
Background: Ovarian cancer is known as the “silent killer”. A prospective psychological evaluation s...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Women with a familial or genetic predisposition to ovarian cancer are at significantly increased ris...
Evaluation of costs and benefits associated with cancer screening should include consideration of an...